AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Ocugen, Inc. Director's Dealing 2024

Mar 20, 2024

32915_dirs_2024-03-20_ac87ec80-6298-4a3e-8b3c-e4275d7b0d2f.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2024-03-18

Reporting Person: Qamar Huma (Chief Medical Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1643	Direct